• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RETRACTABLE TECHNOLOGIES VANISHPOINT INSULIN SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RETRACTABLE TECHNOLOGIES VANISHPOINT INSULIN SYRINGE Back to Search Results
Model Number 15221
Device Problems Insufficient Flow or Under Infusion (2182); Inappropriate or Unexpected Reset (2959)
Patient Problem Underdose (2542)
Event Date 11/13/2015
Event Type  malfunction  
Event Description
The needle retracted by itself during insulin administration, and a substantial amount of the insulin was not injected from the syringe.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VANISHPOINT INSULIN SYRINGE
Type of Device
VANISHPOINT INSULIN SYRINGE
Manufacturer (Section D)
RETRACTABLE TECHNOLOGIES
511 lobo lane
little elm TX 75068
MDR Report Key5256762
MDR Text Key32375943
Report NumberMW5058180
Device Sequence Number1
Product Code MEG
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number15221
Device Lot NumberM140902
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-